Treatment of Parkinson’s disease under the following conditions:• Initial treatment as monotherapy, in order to delay the introduction of levodopa• In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations)."